Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04303325

Effect of Esketamine on Postoperative Depression、Gut Microbiota、Bispectral Index Data of Depression Patients Undergoing Breast Cancer Operation (ESPOD-BI)

Status
Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
72 (estimated)
Sponsor
China Medical University, China · Academic / Other
Sex
Female
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study is a prospective, randomized, controlled (randomized, parallel group, concealed allocation), double-blinded trial. All depression patients undergoing breast cancer operation will be randomized 1:1 to the treatment intervention with general anesthesia as an adjunct to esketamine or saline. The objective of the trial is to evaluate the postoperative depression、gut microbiota、bispectral index data of patients undergoing breast cancer operation with esketamine or saline.

Detailed description

For female patients, breast cancer patients have a high risk of developing depression, and approximately 20%-45% of breast cancer patients suffer from postoperative depression. Esketamine is an anesthetic in analgesia, and has presently become more and more popular for treating anti-depression, particularly for resistant depression. This study is a prospective, randomized, controlled (randomized, parallel group, concealed allocation), double-blinded trial. All depression patients undergoing breast cancer operation will be randomized 1:1 to the treatment intervention with general anesthesia as an adjunct to esketamine or saline. The objective of the trial is to evaluate the postoperative depression、gut microbiota、bispectral index data of patients undergoing breast cancer operation with esketamine or saline

Conditions

Interventions

TypeNameDescription
DRUGEsketamineAll depression patients undergoing breast cancer operation will be to the treatment intervention with general anesthesia as an adjunct to esketamine 0.2mg/kg.
DRUGSaline SolutionAll depression patients undergoing breast cancer operation will be to the treatment intervention with general anesthesia as an adjunct to saline.

Timeline

Start date
2021-10-08
Primary completion
2024-10-30
Completion
2024-12-30
First posted
2020-03-11
Last updated
2024-07-22

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04303325. Inclusion in this directory is not an endorsement.